Vaccination

Covaxin approval requested in US for ages 2-18

US company Ocugen announced Friday that it had asked authorities for emergency use authorization for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

Diseases, Conditions, Syndromes

Antibody blockade effective in treatment of severe COVID-19

As countries around the world race to develop a vaccine for SARS-CoV-2, the virus responsible for COVID-19, researchers are working to understand exactly how it causes the myriad of symptoms that seem to linger long after ...

Neuroscience

Dopamine control of prolactin secretion

In women, a major role of prolactin is to initiate and sustain pregnancy and lactation. During pregnancy, prolactin secretion from the pituitary gland is important for pregnancy maintenance and prolactin levels are correlated ...

page 4 from 30